Cargando…
Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
BACKGROUND: The first- and second-trimester screening for trisomy 21 (T21) are reimbursed for all pregnant women in Belgium. Using a cut-off risk of 1:300 for T21, about 5% of all pregnant women are referred for definitive prenatal diagnosis using an invasive test, at a sensitivity of (only) 72.5%....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225226/ https://www.ncbi.nlm.nih.gov/pubmed/25380810 http://dx.doi.org/10.1136/bmjopen-2014-005922 |